Bayer, Tevra spar over motion to exclude plaintiff expert damages testimony in US antitrust case over flea, tick treatments
MLex Summary: Tevra is attempting to "substitute in an entirely new expert methodology that doubles Tevra’s damages claim, without disclosing any of the data, assumptions, or methods underlying it," Bayer told...To view the full article, register now.
Already a subscriber? Click here to view full article